Foundation Fusion Solutions

Foundation Medicine is a leading molecular information company dedicated to a transformation in cancer care, where treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling (CGP) assays, including FoundationOne CDx and FoundationOne Liquid CDx, which identify all four main classes of genomic alterations and provide insights into biomarkers like tumor mutational burden (TMB) and microsatellite instability (MSI). These solutions help clinicians match patients with appropriate targeted therapies, immunotherapies, and clinical trials. As a subsidiary of Roche, Foundation Medicine also collaborates with biopharmaceutical partners to accelerate the development of precision medicines and companion diagnostics.